News
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
3d
Live Science on MSNDrug slashes migraine days by half in early trial — and it may work with completely 'new mechanism'The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...
A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.
Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...
Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...
People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.
Chronic migraine sufferers who have not been able to find relief with available migraine drugs might now have hope in a new option. A new pilot study from Italian researcher Simone Braca and his ...
A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...
Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...
Dealing with a headache or migraine is never fun, but doctors and dietitians say these foods may offer some relief.
Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results